SCHEDULE 13G

Statement of Beneficial Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2026-02-09 Acc 0001075050-26-000006

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-09 SCHEDULE 13G Statement of Beneficial Ownership
2026-02-04 8-K Other events
2025-05-15 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)